Researchers showed that ∼10% of patients hospitalized for severe tick-borne encephalitis (TBE) carried auto-Abs neutralizing IFN-α2, -β, and/or -ω at the onset of disease, contrasting with only ∼1% of patients with moderate and mild TBE.
[Journal of Experimental Medicine]